Request for Covid-19 Impact Assessment of this Report

Materials and Chemicals

Global Non-Steroidal Anti-Inflammatory API Market Growth 2022-2028

  • LP 4974496
  • 109 Pages
  • July 2022
  • Materials and Chemicals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Non-Steroidal Anti-Inflammatory API will have significant change from previous year. According to our (LP Information) latest study, the global Non-Steroidal Anti-Inflammatory API market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Non-Steroidal Anti-Inflammatory API market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Non-Steroidal Anti-Inflammatory API market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Non-Steroidal Anti-Inflammatory API market, reaching US$ million by the year 2028. As for the Europe Non-Steroidal Anti-Inflammatory API landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Non-Steroidal Anti-Inflammatory API players cover Luan Pharmaceutical, Basf Company, Fengyuan Pharmaceutical, and Xinhua Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Non-Steroidal Anti-Inflammatory API market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Aspirin

Ibuprofen

Naproxen

Diclofenac

Oxapzin

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Medical Pharmaceutical

Scientific Research

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Luan Pharmaceutical

Basf Company

Fengyuan Pharmaceutical

Xinhua Pharmaceutical

Changshu Huagang Pharmaceutical

Hebei Jiheng Group

Zhejiang Kangle Group

Hebei Jingye Medical Technology

Hunan Middle-south Pharmaceutical

Mallinckrodt Pharmaceuticals

IOL

Novacyl

Granules India Limited

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Non-Steroidal Anti-Inflammatory API Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Non-Steroidal Anti-Inflammatory API by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Non-Steroidal Anti-Inflammatory API by Country/Region, 2017, 2022 & 2028

2.2 Non-Steroidal Anti-Inflammatory API Segment by Type

2.2.1 Aspirin

2.2.2 Ibuprofen

2.2.3 Naproxen

2.2.4 Diclofenac

2.2.5 Oxapzin

2.2.6 Others

2.3 Non-Steroidal Anti-Inflammatory API Sales by Type

2.3.1 Global Non-Steroidal Anti-Inflammatory API Sales Market Share by Type (2017-2022)

2.3.2 Global Non-Steroidal Anti-Inflammatory API Revenue and Market Share by Type (2017-2022)

2.3.3 Global Non-Steroidal Anti-Inflammatory API Sale Price by Type (2017-2022)

2.4 Non-Steroidal Anti-Inflammatory API Segment by Application

2.4.1 Medical Pharmaceutical

2.4.2 Scientific Research

2.5 Non-Steroidal Anti-Inflammatory API Sales by Application

2.5.1 Global Non-Steroidal Anti-Inflammatory API Sale Market Share by Application (2017-2022)

2.5.2 Global Non-Steroidal Anti-Inflammatory API Revenue and Market Share by Application (2017-2022)

2.5.3 Global Non-Steroidal Anti-Inflammatory API Sale Price by Application (2017-2022)

3 Global Non-Steroidal Anti-Inflammatory API by Company

3.1 Global Non-Steroidal Anti-Inflammatory API Breakdown Data by Company

3.1.1 Global Non-Steroidal Anti-Inflammatory API Annual Sales by Company (2020-2022)

3.1.2 Global Non-Steroidal Anti-Inflammatory API Sales Market Share by Company (2020-2022)

3.2 Global Non-Steroidal Anti-Inflammatory API Annual Revenue by Company (2020-2022)

3.2.1 Global Non-Steroidal Anti-Inflammatory API Revenue by Company (2020-2022)

3.2.2 Global Non-Steroidal Anti-Inflammatory API Revenue Market Share by Company (2020-2022)

3.3 Global Non-Steroidal Anti-Inflammatory API Sale Price by Company

3.4 Key Manufacturers Non-Steroidal Anti-Inflammatory API Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Non-Steroidal Anti-Inflammatory API Product Location Distribution

3.4.2 Players Non-Steroidal Anti-Inflammatory API Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Non-Steroidal Anti-Inflammatory API by Geographic Region

4.1 World Historic Non-Steroidal Anti-Inflammatory API Market Size by Geographic Region (2017-2022)

4.1.1 Global Non-Steroidal Anti-Inflammatory API Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Non-Steroidal Anti-Inflammatory API Annual Revenue by Geographic Region

4.2 World Historic Non-Steroidal Anti-Inflammatory API Market Size by Country/Region (2017-2022)

4.2.1 Global Non-Steroidal Anti-Inflammatory API Annual Sales by Country/Region (2017-2022)

4.2.2 Global Non-Steroidal Anti-Inflammatory API Annual Revenue by Country/Region

4.3 Americas Non-Steroidal Anti-Inflammatory API Sales Growth

4.4 APAC Non-Steroidal Anti-Inflammatory API Sales Growth

4.5 Europe Non-Steroidal Anti-Inflammatory API Sales Growth

4.6 Middle East & Africa Non-Steroidal Anti-Inflammatory API Sales Growth

5 Americas

5.1 Americas Non-Steroidal Anti-Inflammatory API Sales by Country

5.1.1 Americas Non-Steroidal Anti-Inflammatory API Sales by Country (2017-2022)

5.1.2 Americas Non-Steroidal Anti-Inflammatory API Revenue by Country (2017-2022)

5.2 Americas Non-Steroidal Anti-Inflammatory API Sales by Type

5.3 Americas Non-Steroidal Anti-Inflammatory API Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Non-Steroidal Anti-Inflammatory API Sales by Region

6.1.1 APAC Non-Steroidal Anti-Inflammatory API Sales by Region (2017-2022)

6.1.2 APAC Non-Steroidal Anti-Inflammatory API Revenue by Region (2017-2022)

6.2 APAC Non-Steroidal Anti-Inflammatory API Sales by Type

6.3 APAC Non-Steroidal Anti-Inflammatory API Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Non-Steroidal Anti-Inflammatory API by Country

7.1.1 Europe Non-Steroidal Anti-Inflammatory API Sales by Country (2017-2022)

7.1.2 Europe Non-Steroidal Anti-Inflammatory API Revenue by Country (2017-2022)

7.2 Europe Non-Steroidal Anti-Inflammatory API Sales by Type

7.3 Europe Non-Steroidal Anti-Inflammatory API Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Non-Steroidal Anti-Inflammatory API by Country

8.1.1 Middle East & Africa Non-Steroidal Anti-Inflammatory API Sales by Country (2017-2022)

8.1.2 Middle East & Africa Non-Steroidal Anti-Inflammatory API Revenue by Country (2017-2022)

8.2 Middle East & Africa Non-Steroidal Anti-Inflammatory API Sales by Type

8.3 Middle East & Africa Non-Steroidal Anti-Inflammatory API Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Non-Steroidal Anti-Inflammatory API

10.3 Manufacturing Process Analysis of Non-Steroidal Anti-Inflammatory API

10.4 Industry Chain Structure of Non-Steroidal Anti-Inflammatory API

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Non-Steroidal Anti-Inflammatory API Distributors

11.3 Non-Steroidal Anti-Inflammatory API Customer

12 World Forecast Review for Non-Steroidal Anti-Inflammatory API by Geographic Region

12.1 Global Non-Steroidal Anti-Inflammatory API Market Size Forecast by Region

12.1.1 Global Non-Steroidal Anti-Inflammatory API Forecast by Region (2023-2028)

12.1.2 Global Non-Steroidal Anti-Inflammatory API Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Non-Steroidal Anti-Inflammatory API Forecast by Type

12.7 Global Non-Steroidal Anti-Inflammatory API Forecast by Application

13 Key Players Analysis

13.1 Luan Pharmaceutical

13.1.1 Luan Pharmaceutical Company Information

13.1.2 Luan Pharmaceutical Non-Steroidal Anti-Inflammatory API Product Offered

13.1.3 Luan Pharmaceutical Non-Steroidal Anti-Inflammatory API Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Luan Pharmaceutical Main Business Overview

13.1.5 Luan Pharmaceutical Latest Developments

13.2 Basf Company

13.2.1 Basf Company Company Information

13.2.2 Basf Company Non-Steroidal Anti-Inflammatory API Product Offered

13.2.3 Basf Company Non-Steroidal Anti-Inflammatory API Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Basf Company Main Business Overview

13.2.5 Basf Company Latest Developments

13.3 Fengyuan Pharmaceutical

13.3.1 Fengyuan Pharmaceutical Company Information

13.3.2 Fengyuan Pharmaceutical Non-Steroidal Anti-Inflammatory API Product Offered

13.3.3 Fengyuan Pharmaceutical Non-Steroidal Anti-Inflammatory API Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Fengyuan Pharmaceutical Main Business Overview

13.3.5 Fengyuan Pharmaceutical Latest Developments

13.4 Xinhua Pharmaceutical

13.4.1 Xinhua Pharmaceutical Company Information

13.4.2 Xinhua Pharmaceutical Non-Steroidal Anti-Inflammatory API Product Offered

13.4.3 Xinhua Pharmaceutical Non-Steroidal Anti-Inflammatory API Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Xinhua Pharmaceutical Main Business Overview

13.4.5 Xinhua Pharmaceutical Latest Developments

13.5 Changshu Huagang Pharmaceutical

13.5.1 Changshu Huagang Pharmaceutical Company Information

13.5.2 Changshu Huagang Pharmaceutical Non-Steroidal Anti-Inflammatory API Product Offered

13.5.3 Changshu Huagang Pharmaceutical Non-Steroidal Anti-Inflammatory API Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Changshu Huagang Pharmaceutical Main Business Overview

13.5.5 Changshu Huagang Pharmaceutical Latest Developments

13.6 Hebei Jiheng Group

13.6.1 Hebei Jiheng Group Company Information

13.6.2 Hebei Jiheng Group Non-Steroidal Anti-Inflammatory API Product Offered

13.6.3 Hebei Jiheng Group Non-Steroidal Anti-Inflammatory API Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Hebei Jiheng Group Main Business Overview

13.6.5 Hebei Jiheng Group Latest Developments

13.7 Zhejiang Kangle Group

13.7.1 Zhejiang Kangle Group Company Information

13.7.2 Zhejiang Kangle Group Non-Steroidal Anti-Inflammatory API Product Offered

13.7.3 Zhejiang Kangle Group Non-Steroidal Anti-Inflammatory API Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Zhejiang Kangle Group Main Business Overview

13.7.5 Zhejiang Kangle Group Latest Developments

13.8 Hebei Jingye Medical Technology

13.8.1 Hebei Jingye Medical Technology Company Information

13.8.2 Hebei Jingye Medical Technology Non-Steroidal Anti-Inflammatory API Product Offered

13.8.3 Hebei Jingye Medical Technology Non-Steroidal Anti-Inflammatory API Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Hebei Jingye Medical Technology Main Business Overview

13.8.5 Hebei Jingye Medical Technology Latest Developments

13.9 Hunan Middle-south Pharmaceutical

13.9.1 Hunan Middle-south Pharmaceutical Company Information

13.9.2 Hunan Middle-south Pharmaceutical Non-Steroidal Anti-Inflammatory API Product Offered

13.9.3 Hunan Middle-south Pharmaceutical Non-Steroidal Anti-Inflammatory API Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Hunan Middle-south Pharmaceutical Main Business Overview

13.9.5 Hunan Middle-south Pharmaceutical Latest Developments

13.10 Mallinckrodt Pharmaceuticals

13.10.1 Mallinckrodt Pharmaceuticals Company Information

13.10.2 Mallinckrodt Pharmaceuticals Non-Steroidal Anti-Inflammatory API Product Offered

13.10.3 Mallinckrodt Pharmaceuticals Non-Steroidal Anti-Inflammatory API Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Mallinckrodt Pharmaceuticals Main Business Overview

13.10.5 Mallinckrodt Pharmaceuticals Latest Developments

13.11 IOL

13.11.1 IOL Company Information

13.11.2 IOL Non-Steroidal Anti-Inflammatory API Product Offered

13.11.3 IOL Non-Steroidal Anti-Inflammatory API Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 IOL Main Business Overview

13.11.5 IOL Latest Developments

13.12 Novacyl

13.12.1 Novacyl Company Information

13.12.2 Novacyl Non-Steroidal Anti-Inflammatory API Product Offered

13.12.3 Novacyl Non-Steroidal Anti-Inflammatory API Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Novacyl Main Business Overview

13.12.5 Novacyl Latest Developments

13.13 Granules India Limited

13.13.1 Granules India Limited Company Information

13.13.2 Granules India Limited Non-Steroidal Anti-Inflammatory API Product Offered

13.13.3 Granules India Limited Non-Steroidal Anti-Inflammatory API Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Granules India Limited Main Business Overview

13.13.5 Granules India Limited Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Non-Steroidal Anti-Inflammatory API Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Non-Steroidal Anti-Inflammatory API Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Aspirin

Table 4. Major Players of Ibuprofen

Table 5. Major Players of Naproxen

Table 6. Major Players of Diclofenac

Table 7. Major Players of Oxapzin

Table 8. Major Players of Others

Table 9. Global Non-Steroidal Anti-Inflammatory API Sales by Type (2017-2022) & (Tons)

Table 10. Global Non-Steroidal Anti-Inflammatory API Sales Market Share by Type (2017-2022)

Table 11. Global Non-Steroidal Anti-Inflammatory API Revenue by Type (2017-2022) & ($ million)

Table 12. Global Non-Steroidal Anti-Inflammatory API Revenue Market Share by Type (2017-2022)

Table 13. Global Non-Steroidal Anti-Inflammatory API Sale Price by Type (2017-2022) & (US$/Kg)

Table 14. Global Non-Steroidal Anti-Inflammatory API Sales by Application (2017-2022) & (Tons)

Table 15. Global Non-Steroidal Anti-Inflammatory API Sales Market Share by Application (2017-2022)

Table 16. Global Non-Steroidal Anti-Inflammatory API Revenue by Application (2017-2022)

Table 17. Global Non-Steroidal Anti-Inflammatory API Revenue Market Share by Application (2017-2022)

Table 18. Global Non-Steroidal Anti-Inflammatory API Sale Price by Application (2017-2022) & (US$/Kg)

Table 19. Global Non-Steroidal Anti-Inflammatory API Sales by Company (2020-2022) & (Tons)

Table 20. Global Non-Steroidal Anti-Inflammatory API Sales Market Share by Company (2020-2022)

Table 21. Global Non-Steroidal Anti-Inflammatory API Revenue by Company (2020-2022) ($ Millions)

Table 22. Global Non-Steroidal Anti-Inflammatory API Revenue Market Share by Company (2020-2022)

Table 23. Global Non-Steroidal Anti-Inflammatory API Sale Price by Company (2020-2022) & (US$/Kg)

Table 24. Key Manufacturers Non-Steroidal Anti-Inflammatory API Producing Area Distribution and Sales Area

Table 25. Players Non-Steroidal Anti-Inflammatory API Products Offered

Table 26. Non-Steroidal Anti-Inflammatory API Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global Non-Steroidal Anti-Inflammatory API Sales by Geographic Region (2017-2022) & (Tons)

Table 30. Global Non-Steroidal Anti-Inflammatory API Sales Market Share Geographic Region (2017-2022)

Table 31. Global Non-Steroidal Anti-Inflammatory API Revenue by Geographic Region (2017-2022) & ($ millions)

Table 32. Global Non-Steroidal Anti-Inflammatory API Revenue Market Share by Geographic Region (2017-2022)

Table 33. Global Non-Steroidal Anti-Inflammatory API Sales by Country/Region (2017-2022) & (Tons)

Table 34. Global Non-Steroidal Anti-Inflammatory API Sales Market Share by Country/Region (2017-2022)

Table 35. Global Non-Steroidal Anti-Inflammatory API Revenue by Country/Region (2017-2022) & ($ millions)

Table 36. Global Non-Steroidal Anti-Inflammatory API Revenue Market Share by Country/Region (2017-2022)

Table 37. Americas Non-Steroidal Anti-Inflammatory API Sales by Country (2017-2022) & (Tons)

Table 38. Americas Non-Steroidal Anti-Inflammatory API Sales Market Share by Country (2017-2022)

Table 39. Americas Non-Steroidal Anti-Inflammatory API Revenue by Country (2017-2022) & ($ Millions)

Table 40. Americas Non-Steroidal Anti-Inflammatory API Revenue Market Share by Country (2017-2022)

Table 41. Americas Non-Steroidal Anti-Inflammatory API Sales by Type (2017-2022) & (Tons)

Table 42. Americas Non-Steroidal Anti-Inflammatory API Sales Market Share by Type (2017-2022)

Table 43. Americas Non-Steroidal Anti-Inflammatory API Sales by Application (2017-2022) & (Tons)

Table 44. Americas Non-Steroidal Anti-Inflammatory API Sales Market Share by Application (2017-2022)

Table 45. APAC Non-Steroidal Anti-Inflammatory API Sales by Region (2017-2022) & (Tons)

Table 46. APAC Non-Steroidal Anti-Inflammatory API Sales Market Share by Region (2017-2022)

Table 47. APAC Non-Steroidal Anti-Inflammatory API Revenue by Region (2017-2022) & ($ Millions)

Table 48. APAC Non-Steroidal Anti-Inflammatory API Revenue Market Share by Region (2017-2022)

Table 49. APAC Non-Steroidal Anti-Inflammatory API Sales by Type (2017-2022) & (Tons)

Table 50. APAC Non-Steroidal Anti-Inflammatory API Sales Market Share by Type (2017-2022)

Table 51. APAC Non-Steroidal Anti-Inflammatory API Sales by Application (2017-2022) & (Tons)

Table 52. APAC Non-Steroidal Anti-Inflammatory API Sales Market Share by Application (2017-2022)

Table 53. Europe Non-Steroidal Anti-Inflammatory API Sales by Country (2017-2022) & (Tons)

Table 54. Europe Non-Steroidal Anti-Inflammatory API Sales Market Share by Country (2017-2022)

Table 55. Europe Non-Steroidal Anti-Inflammatory API Revenue by Country (2017-2022) & ($ Millions)

Table 56. Europe Non-Steroidal Anti-Inflammatory API Revenue Market Share by Country (2017-2022)

Table 57. Europe Non-Steroidal Anti-Inflammatory API Sales by Type (2017-2022) & (Tons)

Table 58. Europe Non-Steroidal Anti-Inflammatory API Sales Market Share by Type (2017-2022)

Table 59. Europe Non-Steroidal Anti-Inflammatory API Sales by Application (2017-2022) & (Tons)

Table 60. Europe Non-Steroidal Anti-Inflammatory API Sales Market Share by Application (2017-2022)

Table 61. Middle East & Africa Non-Steroidal Anti-Inflammatory API Sales by Country (2017-2022) & (Tons)

Table 62. Middle East & Africa Non-Steroidal Anti-Inflammatory API Sales Market Share by Country (2017-2022)

Table 63. Middle East & Africa Non-Steroidal Anti-Inflammatory API Revenue by Country (2017-2022) & ($ Millions)

Table 64. Middle East & Africa Non-Steroidal Anti-Inflammatory API Revenue Market Share by Country (2017-2022)

Table 65. Middle East & Africa Non-Steroidal Anti-Inflammatory API Sales by Type (2017-2022) & (Tons)

Table 66. Middle East & Africa Non-Steroidal Anti-Inflammatory API Sales Market Share by Type (2017-2022)

Table 67. Middle East & Africa Non-Steroidal Anti-Inflammatory API Sales by Application (2017-2022) & (Tons)

Table 68. Middle East & Africa Non-Steroidal Anti-Inflammatory API Sales Market Share by Application (2017-2022)

Table 69. Key Market Drivers & Growth Opportunities of Non-Steroidal Anti-Inflammatory API

Table 70. Key Market Challenges & Risks of Non-Steroidal Anti-Inflammatory API

Table 71. Key Industry Trends of Non-Steroidal Anti-Inflammatory API

Table 72. Non-Steroidal Anti-Inflammatory API Raw Material

Table 73. Key Suppliers of Raw Materials

Table 74. Non-Steroidal Anti-Inflammatory API Distributors List

Table 75. Non-Steroidal Anti-Inflammatory API Customer List

Table 76. Global Non-Steroidal Anti-Inflammatory API Sales Forecast by Region (2023-2028) & (Tons)

Table 77. Global Non-Steroidal Anti-Inflammatory API Sales Market Forecast by Region

Table 78. Global Non-Steroidal Anti-Inflammatory API Revenue Forecast by Region (2023-2028) & ($ millions)

Table 79. Global Non-Steroidal Anti-Inflammatory API Revenue Market Share Forecast by Region (2023-2028)

Table 80. Americas Non-Steroidal Anti-Inflammatory API Sales Forecast by Country (2023-2028) & (Tons)

Table 81. Americas Non-Steroidal Anti-Inflammatory API Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. APAC Non-Steroidal Anti-Inflammatory API Sales Forecast by Region (2023-2028) & (Tons)

Table 83. APAC Non-Steroidal Anti-Inflammatory API Revenue Forecast by Region (2023-2028) & ($ millions)

Table 84. Europe Non-Steroidal Anti-Inflammatory API Sales Forecast by Country (2023-2028) & (Tons)

Table 85. Europe Non-Steroidal Anti-Inflammatory API Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Middle East & Africa Non-Steroidal Anti-Inflammatory API Sales Forecast by Country (2023-2028) & (Tons)

Table 87. Middle East & Africa Non-Steroidal Anti-Inflammatory API Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Global Non-Steroidal Anti-Inflammatory API Sales Forecast by Type (2023-2028) & (Tons)

Table 89. Global Non-Steroidal Anti-Inflammatory API Sales Market Share Forecast by Type (2023-2028)

Table 90. Global Non-Steroidal Anti-Inflammatory API Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 91. Global Non-Steroidal Anti-Inflammatory API Revenue Market Share Forecast by Type (2023-2028)

Table 92. Global Non-Steroidal Anti-Inflammatory API Sales Forecast by Application (2023-2028) & (Tons)

Table 93. Global Non-Steroidal Anti-Inflammatory API Sales Market Share Forecast by Application (2023-2028)

Table 94. Global Non-Steroidal Anti-Inflammatory API Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 95. Global Non-Steroidal Anti-Inflammatory API Revenue Market Share Forecast by Application (2023-2028)

Table 96. Luan Pharmaceutical Basic Information, Non-Steroidal Anti-Inflammatory API Manufacturing Base, Sales Area and Its Competitors

Table 97. Luan Pharmaceutical Non-Steroidal Anti-Inflammatory API Product Offered

Table 98. Luan Pharmaceutical Non-Steroidal Anti-Inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 99. Luan Pharmaceutical Main Business

Table 100. Luan Pharmaceutical Latest Developments

Table 101. Basf Company Basic Information, Non-Steroidal Anti-Inflammatory API Manufacturing Base, Sales Area and Its Competitors

Table 102. Basf Company Non-Steroidal Anti-Inflammatory API Product Offered

Table 103. Basf Company Non-Steroidal Anti-Inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 104. Basf Company Main Business

Table 105. Basf Company Latest Developments

Table 106. Fengyuan Pharmaceutical Basic Information, Non-Steroidal Anti-Inflammatory API Manufacturing Base, Sales Area and Its Competitors

Table 107. Fengyuan Pharmaceutical Non-Steroidal Anti-Inflammatory API Product Offered

Table 108. Fengyuan Pharmaceutical Non-Steroidal Anti-Inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 109. Fengyuan Pharmaceutical Main Business

Table 110. Fengyuan Pharmaceutical Latest Developments

Table 111. Xinhua Pharmaceutical Basic Information, Non-Steroidal Anti-Inflammatory API Manufacturing Base, Sales Area and Its Competitors

Table 112. Xinhua Pharmaceutical Non-Steroidal Anti-Inflammatory API Product Offered

Table 113. Xinhua Pharmaceutical Non-Steroidal Anti-Inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 114. Xinhua Pharmaceutical Main Business

Table 115. Xinhua Pharmaceutical Latest Developments

Table 116. Changshu Huagang Pharmaceutical Basic Information, Non-Steroidal Anti-Inflammatory API Manufacturing Base, Sales Area and Its Competitors

Table 117. Changshu Huagang Pharmaceutical Non-Steroidal Anti-Inflammatory API Product Offered

Table 118. Changshu Huagang Pharmaceutical Non-Steroidal Anti-Inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 119. Changshu Huagang Pharmaceutical Main Business

Table 120. Changshu Huagang Pharmaceutical Latest Developments

Table 121. Hebei Jiheng Group Basic Information, Non-Steroidal Anti-Inflammatory API Manufacturing Base, Sales Area and Its Competitors

Table 122. Hebei Jiheng Group Non-Steroidal Anti-Inflammatory API Product Offered

Table 123. Hebei Jiheng Group Non-Steroidal Anti-Inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 124. Hebei Jiheng Group Main Business

Table 125. Hebei Jiheng Group Latest Developments

Table 126. Zhejiang Kangle Group Basic Information, Non-Steroidal Anti-Inflammatory API Manufacturing Base, Sales Area and Its Competitors

Table 127. Zhejiang Kangle Group Non-Steroidal Anti-Inflammatory API Product Offered

Table 128. Zhejiang Kangle Group Non-Steroidal Anti-Inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 129. Zhejiang Kangle Group Main Business

Table 130. Zhejiang Kangle Group Latest Developments

Table 131. Hebei Jingye Medical Technology Basic Information, Non-Steroidal Anti-Inflammatory API Manufacturing Base, Sales Area and Its Competitors

Table 132. Hebei Jingye Medical Technology Non-Steroidal Anti-Inflammatory API Product Offered

Table 133. Hebei Jingye Medical Technology Non-Steroidal Anti-Inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 134. Hebei Jingye Medical Technology Main Business

Table 135. Hebei Jingye Medical Technology Latest Developments

Table 136. Hunan Middle-south Pharmaceutical Basic Information, Non-Steroidal Anti-Inflammatory API Manufacturing Base, Sales Area and Its Competitors

Table 137. Hunan Middle-south Pharmaceutical Non-Steroidal Anti-Inflammatory API Product Offered

Table 138. Hunan Middle-south Pharmaceutical Non-Steroidal Anti-Inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 139. Hunan Middle-south Pharmaceutical Main Business

Table 140. Hunan Middle-south Pharmaceutical Latest Developments

Table 141. Mallinckrodt Pharmaceuticals Basic Information, Non-Steroidal Anti-Inflammatory API Manufacturing Base, Sales Area and Its Competitors

Table 142. Mallinckrodt Pharmaceuticals Non-Steroidal Anti-Inflammatory API Product Offered

Table 143. Mallinckrodt Pharmaceuticals Non-Steroidal Anti-Inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 144. Mallinckrodt Pharmaceuticals Main Business

Table 145. Mallinckrodt Pharmaceuticals Latest Developments

Table 146. IOL Basic Information, Non-Steroidal Anti-Inflammatory API Manufacturing Base, Sales Area and Its Competitors

Table 147. IOL Non-Steroidal Anti-Inflammatory API Product Offered

Table 148. IOL Non-Steroidal Anti-Inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 149. IOL Main Business

Table 150. IOL Latest Developments

Table 151. Novacyl Basic Information, Non-Steroidal Anti-Inflammatory API Manufacturing Base, Sales Area and Its Competitors

Table 152. Novacyl Non-Steroidal Anti-Inflammatory API Product Offered

Table 153. Novacyl Non-Steroidal Anti-Inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 154. Novacyl Main Business

Table 155. Novacyl Latest Developments

Table 156. Granules India Limited Basic Information, Non-Steroidal Anti-Inflammatory API Manufacturing Base, Sales Area and Its Competitors

Table 157. Granules India Limited Non-Steroidal Anti-Inflammatory API Product Offered

Table 158. Granules India Limited Non-Steroidal Anti-Inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 159. Granules India Limited Main Business

Table 160. Granules India Limited Latest Developments

List of Figures

Figure 1. Picture of Non-Steroidal Anti-Inflammatory API

Figure 2. Non-Steroidal Anti-Inflammatory API Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Non-Steroidal Anti-Inflammatory API Sales Growth Rate 2017-2028 (Tons)

Figure 7. Global Non-Steroidal Anti-Inflammatory API Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Non-Steroidal Anti-Inflammatory API Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Aspirin

Figure 10. Product Picture of Ibuprofen

Figure 11. Product Picture of Naproxen

Figure 12. Product Picture of Diclofenac

Figure 13. Product Picture of Oxapzin

Figure 14. Product Picture of Others

Figure 15. Global Non-Steroidal Anti-Inflammatory API Sales Market Share by Type in 2021

Figure 16. Global Non-Steroidal Anti-Inflammatory API Revenue Market Share by Type (2017-2022)

Figure 17. Non-Steroidal Anti-Inflammatory API Consumed in Medical Pharmaceutical

Figure 18. Global Non-Steroidal Anti-Inflammatory API Market: Medical Pharmaceutical (2017-2022) & (Tons)

Figure 19. Non-Steroidal Anti-Inflammatory API Consumed in Scientific Research

Figure 20. Global Non-Steroidal Anti-Inflammatory API Market: Scientific Research (2017-2022) & (Tons)

Figure 21. Global Non-Steroidal Anti-Inflammatory API Sales Market Share by Application (2017-2022)

Figure 22. Global Non-Steroidal Anti-Inflammatory API Revenue Market Share by Application in 2021

Figure 23. Non-Steroidal Anti-Inflammatory API Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Non-Steroidal Anti-Inflammatory API Revenue Market Share by Company in 2021

Figure 25. Global Non-Steroidal Anti-Inflammatory API Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Non-Steroidal Anti-Inflammatory API Revenue Market Share by Geographic Region in 2021

Figure 27. Global Non-Steroidal Anti-Inflammatory API Sales Market Share by Region (2017-2022)

Figure 28. Global Non-Steroidal Anti-Inflammatory API Revenue Market Share by Country/Region in 2021

Figure 29. Americas Non-Steroidal Anti-Inflammatory API Sales 2017-2022 (Tons)

Figure 30. Americas Non-Steroidal Anti-Inflammatory API Revenue 2017-2022 ($ Millions)

Figure 31. APAC Non-Steroidal Anti-Inflammatory API Sales 2017-2022 (Tons)

Figure 32. APAC Non-Steroidal Anti-Inflammatory API Revenue 2017-2022 ($ Millions)

Figure 33. Europe Non-Steroidal Anti-Inflammatory API Sales 2017-2022 (Tons)

Figure 34. Europe Non-Steroidal Anti-Inflammatory API Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Non-Steroidal Anti-Inflammatory API Sales 2017-2022 (Tons)

Figure 36. Middle East & Africa Non-Steroidal Anti-Inflammatory API Revenue 2017-2022 ($ Millions)

Figure 37. Americas Non-Steroidal Anti-Inflammatory API Sales Market Share by Country in 2021

Figure 38. Americas Non-Steroidal Anti-Inflammatory API Revenue Market Share by Country in 2021

Figure 39. United States Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Non-Steroidal Anti-Inflammatory API Sales Market Share by Region in 2021

Figure 44. APAC Non-Steroidal Anti-Inflammatory API Revenue Market Share by Regions in 2021

Figure 45. China Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Non-Steroidal Anti-Inflammatory API Sales Market Share by Country in 2021

Figure 52. Europe Non-Steroidal Anti-Inflammatory API Revenue Market Share by Country in 2021

Figure 53. Germany Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Non-Steroidal Anti-Inflammatory API Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Non-Steroidal Anti-Inflammatory API Revenue Market Share by Country in 2021

Figure 60. Egypt Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Non-Steroidal Anti-Inflammatory API in 2021

Figure 66. Manufacturing Process Analysis of Non-Steroidal Anti-Inflammatory API

Figure 67. Industry Chain Structure of Non-Steroidal Anti-Inflammatory API

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Global Photonic Crystals Market (Construction Strategies, Geography , Applications) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Photonic Crystals are attractive optical materials for controlling and manipulating the flow of light. The global market for components and modules using Photonic Crystals indicates a CAGR of 33.1% and is estimated to reach $20.4 billion in 2017.

  • Publish Date: February 8, 2017
  • $5370
Molded Plastics Market by Product (Polyvinyl Chloride, Polypropylene, Polystyrene, Low Density Polyethylene, High Density Polyethylene, Polyethylene Terephthalate, and Engineering Plastics), Technology (Injection Molding, Blow Molding, Extrusion, and Others), and Application (Building & Construction, Electrical & Electronics, Automotive and Packaging) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Global molded plastics market was valued at $529,845 million in 2016, and is expected to garner $690,158 million by 2023, registering a CAGR of 3.9% from 2017 to 2023. Molded plastics are synthetically produced non-metallic compounds, which can be molded ...

  • Publish Date: July 4, 2017
  • $5370